Earlier anticoagulation after ischemic stroke reduces recurrence
Why it matters. Randomized evidence on timing, directly relevant to an acute decision, with a favorable bleeding profile.
PeerCurrent turns the flood of scientific knowledge into a personalized, intelligent feed: summarized, organized and discussed by researchers, clinicians and industry professionals. Launching in life sciences, it helps you follow the diseases, therapies, companies, trials, publications and experts that matter to your work.
Why it matters. Large randomized data may move the timing of a decision you make weekly.
Why it matters. Consistent effect strengthens a growing prescribing case.
PeerCurrent does the reading and the judging, so your attention goes only where it counts.
The developments in your specialty since you last looked, pulled from journals, trials, guidelines, agencies, and preprints.
Plain-language context tied to your role and the topics you follow, so relevance is obvious in seconds.
A transparent, multidimensional read of the evidence, graded from the source, so you can trust it or challenge it.
One development per card. Swipe to move on, tap to open the full analysis and its source. This is the real feel of the mobile app.
Why it matters. Randomized evidence on timing, directly relevant to an acute decision, with a favorable bleeding profile.
Why it matters. Pooled across nine trials, the direction and size of effect are consistent.
Why it matters. Observational, so promising rather than definitive, but a signal worth watching.
Why it matters. Prescribing guidance you should know before your next script.
Every development is assessed across the dimensions that decide whether you should act, each graded only from what the source actually supports, and never invented.
What changed, the numbers that matter, how strong it is, what it changes in practice, and the caveat. Written the way a trusted colleague would summarize it to you, then linked straight to the paper so you can verify in one tap.
No fabricated statistics. No single opaque rating. When the evidence does not support a firm read, it says so.
Pick your specialty and the topics you track. Your briefing is ranked for you from the first morning.
Each morning, the developments that matter, graded and explained, with the noise already filtered out.
Open the full analysis, check the source, save it, or share your read with colleagues. All in a few taps.
PeerCurrent starts with practicing clinicians, and the same engine extends to the people who work alongside the evidence.
Stay current in your specialty without the doomscroll. Know what changed and whether it changes your management.
Track your field across journals and preprints, connect findings, and never miss a result that touches your work.On the roadmap
Follow the research, trial readouts, and regulatory actions behind the companies you watch. Information, not advice.On the roadmap
Full access for 7 days. Keep it if it earns a place in your morning.
Peer-reviewed journals, clinical trial registries, guidelines, regulatory agencies, and preprints. Every item links to its original source so you can read it yourself in one tap.
Each development is assessed across dimensions like study design, directness, consistency, risk of bias, and sample adequacy, graded only from what the source supports. You always see the reasoning, never a single mystery score, and it says so plainly when the evidence is thin.
Yes. You choose your field and the topics, journals, and agencies you follow, and your briefing is ranked for you, with a short note on why each item is in front of you.
You get 7 days of full access to decide if it earns a place in your morning. Keep it with a monthly or annual plan when you are ready.
No. PeerCurrent surfaces and summarizes evidence to support your judgment. Clinical decisions remain yours, and you should always confirm against the original source before acting.
Give PeerCurrent one week. If your first briefing does not save you time and sharpen your read of the evidence, walk away.
Start your free week